Bristol Myers Squibb Fellowship - UNC Eshelman School of Pharmacy

This fellowship is sponsored in collaboration with BMS https://www.bms.com/ and is part of the DPET fellowship program.

Length: Two years

This postdoctoral fellowship program enables fellows to gain research expertise in drug development, quantitative pharmacology, and translational research while preparing them for careers as clinical pharmacologist or clinical pharmacokineticist and simulation in an industrial, academic, or regulatory setting.

The ideal candidate should have a minimum of a Pharm.D., Ph.D., or M.D. with knowledge of PK/PD analyses. Excellent communication skills and ability to work independently as well as a member of an interdisciplinary team are essential.

Program Description

The UNC Eshelman School of Pharmacy and BMS offers a two-year postdoctoral fellowship in pharmacokinetics/pharmacodynamics (PK/PD) modeling. The fellowship emphasizes coursework and hands-on experience focused on the application of mechanism-based, population and physiologically-based PK/PD modeling and simulation techniques to guide drug development. Fellows spend their first year at the University of North Carolina at Chapel Hill, and the second year at BMS.

At the completion of the Fellowship, the post-doctoral fellow will be able to:

Describe the importance of clinical research in drug development;
Describe the nature and relevance of clinical data evaluations relative to drug development;
Design and implement studies to examine drug absorption, drug disposition, pharmacodynamic endpoints and drug interactions in healthy human volunteers or diseased patient populations;
Understand foundational concepts of PK and PD, mechanism-based, population and physiologically-based PK modeling and simulation techniques;
Understand important considerations in clinical trial design and the conduct of clinical investigations in specific patient populations;
Perform PK/PD and statistical data analysis and PBPK modeling using relevant software packages;
Prepare a manuscript, seminar and other scholarly vehicles for communication of scientific results.

About BMS

Bristol Myers Squibb (BMS) is a global biopharmaceutical company committed to a single mission: to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Around the world, our medicines help millions of people in their fight against neoplastic, cardiovascular, and immunological diseases.